Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
NewAmsterdam Pharma Co N.V.Listing on record | Sell | $1.3M | SEC | |
NewAmsterdam Pharma Co N.V.Listing on record | Sell | $132.7K | SEC | |
NewAmsterdam Pharma Co N.V.Listing on record | Sell | $490.8K | SEC | |
NewAmsterdam Pharma Co N.V.Listing on record | Sell | $3.3M | SEC | |
NewAmsterdam Pharma Co N.V.Listing on record | Sell | $6.6M | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $5M | SEC | |
Forbion European Acquisition Corp.Listing unverified | OtherD (derivative) | — | SEC | |
Forbion European Acquisition Corp.Listing unverified | Other | — | SEC | |
Forbion European Acquisition Corp.Listing unverified | AwardD (derivative) | $1.5M | SEC |